Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
This study has been completed.
Study NCT00947297 Information provided by Hyperion Therapeutics, Inc.
First Received on July 24, 2009. Last Updated on July 15, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urea Cycle Disorders
Additional conditions recognized in this trial
Urea Cycle Disorders, Inborn
More general conditions related to this trial
Amino Acid Metabolism, Inborn Errors
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Genetic Diseases, Inborn
Metabolism, Inborn Errors
Nervous System Diseases
Interventions listed in this trial
Sponsors listed in this trial
Hyperion Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers